ZA919438B - Use of xanthines for the preparation of a medicament having immuno supressing activity - Google Patents

Use of xanthines for the preparation of a medicament having immuno supressing activity

Info

Publication number
ZA919438B
ZA919438B ZA919438A ZA919438A ZA919438B ZA 919438 B ZA919438 B ZA 919438B ZA 919438 A ZA919438 A ZA 919438A ZA 919438 A ZA919438 A ZA 919438A ZA 919438 B ZA919438 B ZA 919438B
Authority
ZA
South Africa
Prior art keywords
supressing
xanthines
immuno
medicament
activity
Prior art date
Application number
ZA919438A
Other languages
English (en)
Inventor
James A Bianco
A Bianco James
Jack W Singer
W Singer Jack
William J Novick Jr
J Novick William Jr
Original Assignee
Hoechst Roussel Pharma
Hutchinson Fred Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma, Hutchinson Fred Cancer Res filed Critical Hoechst Roussel Pharma
Publication of ZA919438B publication Critical patent/ZA919438B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA919438A 1990-11-30 1991-11-29 Use of xanthines for the preparation of a medicament having immuno supressing activity ZA919438B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62048090A 1990-11-30 1990-11-30

Publications (1)

Publication Number Publication Date
ZA919438B true ZA919438B (en) 1992-08-26

Family

ID=24486121

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA919438A ZA919438B (en) 1990-11-30 1991-11-29 Use of xanthines for the preparation of a medicament having immuno supressing activity

Country Status (10)

Country Link
EP (1) EP0490181A1 (enExample)
JP (1) JPH06100450A (enExample)
KR (1) KR920009399A (enExample)
CA (1) CA2056723A1 (enExample)
HU (1) HUT59825A (enExample)
IE (1) IE914163A1 (enExample)
IL (1) IL100195A0 (enExample)
PT (1) PT99659A (enExample)
TW (1) TW205507B (enExample)
ZA (1) ZA919438B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992021344A2 (en) * 1991-05-24 1992-12-10 Fred Hutchinson Cancer Research Center Modulation of cellular response to external stimuli
DE4411660A1 (de) * 1994-04-05 1995-10-12 Hoechst Ag Verwendung von Xanthinderivaten zur Reduktion der pathologischen Hyperreagibilität eosinophiler Granulozyten, neue Xanthinverbindungen und Verfahren zu deren Herstellung
DE4430128A1 (de) * 1994-08-25 1996-02-29 Hoechst Ag Kombinationspräparat mit immunsuppressiven, kardiovaskulären und cerebralen Wirkungen
DE4430127A1 (de) * 1994-08-25 1996-03-14 Hoechst Ag Kombinationspräparat, enthaltend Cyclosporin A oder FK506 und ein Xanthinderivat
US6323201B1 (en) 1994-12-29 2001-11-27 The Regents Of The University Of California Compounds for inhibition of ceramide-mediated signal transduction
EP0956855B1 (en) * 1998-04-24 2003-03-12 K.U. Leuven Research & Development Immunosuppressive effects of 8 substituted xanthine derivatives
US6930101B1 (en) 1999-05-17 2005-08-16 The Regents Of The University Of California Thiazolopyrimidines useful as TNFα inhibitors
US7253176B1 (en) 2000-05-04 2007-08-07 K.U. Leuven Research & Development Immunosuppressive effects of 8-substituted xanthine derivatives
KR20100121527A (ko) 2008-02-29 2010-11-17 콘서트 파마슈티컬즈, 인크. 치환된 잔틴 유도체
US20110053961A1 (en) 2009-02-27 2011-03-03 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
IN2012DN01642A (enExample) 2009-09-02 2015-06-05 Concert Pharmaceuticals Inc
EP2611807A2 (en) 2010-09-01 2013-07-10 Concert Pharmaceuticals Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)dione
US20140296263A1 (en) 2011-07-19 2014-10-02 Concert Pharmaceuticals, Inc. Substituted xanthine derivatives
MX2014012384A (es) 2012-04-13 2014-11-26 Concert Pharmaceuticals Inc Derivados sustituidos de xantina.
WO2013159006A1 (en) 2012-04-20 2013-10-24 Concert Pharmaceuticals, Inc. Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3,7-dimethyl-1h-purine-2,6(3h,7h)-dione
US9549869B2 (en) 2012-06-29 2017-01-24 Hill-Rom Canado Respiratory Ltd. Wearable thorax percussion device

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063827B1 (fr) * 1980-05-02 1985-08-14 Societe Des Produits Nestle S.A. 1-Isopropyl- et 1-isobutyl-3,7-diméthylxanthine comme médicaments
IL84934A (en) * 1986-12-31 1994-08-26 Hoechst Roussel Pharma Pharmaceutical preparations containing xanthan history to stop the activity of interleukin-1 and leukocyte-derived cytokines
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
GB8918297D0 (en) * 1989-08-10 1989-09-20 Beecham Group Plc Novel treatment

Also Published As

Publication number Publication date
CA2056723A1 (en) 1992-05-31
PT99659A (pt) 1992-10-30
HUT59825A (en) 1992-07-28
IE914163A1 (en) 1992-06-03
HU913721D0 (en) 1992-02-28
IL100195A0 (en) 1992-08-18
TW205507B (enExample) 1993-05-11
EP0490181A1 (en) 1992-06-17
JPH06100450A (ja) 1994-04-12
KR920009399A (ko) 1992-06-25

Similar Documents

Publication Publication Date Title
GB9011588D0 (en) Prostaglandin analogues for use in medicine
GB9219999D0 (en) Preparation of a medicament
GR890100579A (en) Consolidated sanitary napkin structure
ZA911451B (en) Clinical bed
GB8828477D0 (en) Medical aerosol formulations
GB2255503B (en) Improved use of ß2-bronchodilator drugs
ZA919438B (en) Use of xanthines for the preparation of a medicament having immuno supressing activity
GB8911259D0 (en) Inhalation medicament
GB9000241D0 (en) Pharmaceutical use
EP0467537A3 (en) Novel benzothiazepine esters, their preparation and formulations for therapeutic use
GB9010038D0 (en) Preparation of a medicament
GB8802391D0 (en) Medicinal formulations
IE882467L (en) Pharmaceutical preparation for external use
GB9025377D0 (en) Compounds having antiviral and cytotoxic activity
GB9017548D0 (en) Therapeutic preparation
GB8816731D0 (en) Tonometer
GB9013657D0 (en) Disposable napkin
GB9022711D0 (en) A novel use of a therapeutic agent
HU905867D0 (en) Medical preparation
GB8829873D0 (en) Preparation of an artefact
GB9004831D0 (en) Pharmaceutical preparation
HU908149D0 (en) Medical napkins
GB9022669D0 (en) Medicament
GB9006432D0 (en) Prostagladin analogues for use in medicine
GB8901158D0 (en) Administering drugs